Links

Tools

Export citation

Search in Google Scholar

A Nordic phase II study on dose-intensive induction and high-dose therapy (HDT) with autologous stem cell rescue (ASCR) as primary treatment for peripheral T-cell lymphomas (PTCL)

This paper was not found in any repository; the policy of its publisher is unknown or unclear.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Question mark in circle
Preprint: policy unknown
Question mark in circle
Postprint: policy unknown
Question mark in circle
Published version: policy unknown